Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our proprietary precision gene editing technology. Our technology utilizes novel CRISPR-Cas gene editors coupled with anti-CRISPR proteins to improve the precision, efficacy, and safety of genetic therapies. The company was co-founded in 2019 by Dr. Joseph Bondy-Denomy (Associate Professor at UCSF and discoverer of anti-CRISPR proteins) and Dr. David Rabuka (former Founder and CSO of Redwood Biosciences) with the mission of bringing precision genetic therapies to the clinic.
View Top Employees from Acrigen Biosciences| Website | https://www.acrigen.com/ |
| Employees | 9 (8 on RocketReach) |
| Founded | 2019 |
| Address | 1000 Atlantic Ave Suite 104, Alameda, California 94501, US |
| Technologies |
JavaScript,
HTML,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology |
Looking for a particular Acrigen Biosciences employee's phone or email?
Acrigen Biosciences Questions
Michael Schelle is the Vice President of Research and Operations of Acrigen Biosciences.
8 people are employed at Acrigen Biosciences.
Acrigen Biosciences is based in Alameda, California.
Top Acrigen Biosciences Employees
-
13
-
ViewMichael Schelle
Vice President of Research and Operations at Acrigen Biosciences
California, United States33 -
21
-
2
-
1
-
11
Related Companies
